Chemotherapy-induced neutropenia
Blood Disorders
Chemotherapy-induced neutropenia is treated with 5 medications in our database, including RYZNEUTA, Rolvedon, Fulphila, ARMLUPEG, UDENYCA. 3 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Evive, Assertio, Biocon, Coherus BioSciences. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Chemotherapy-induced neutropenia treatment below.
What help exists for Chemotherapy-induced neutropenia
5
drugs indexed
4
with copay cards
4
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Chemotherapy-induced neutropenia
5 totalUDENYCA
pegfilgrastim-cbqv · Coherus BioSciences
🎟💙RYZNEUTA
efbemalenograstim alfa-vuxw · Evive
🎟💙ARMLUPEG
pegfilgrastim-unne
Fulphila
pegfilgrastim-jmdb · Biocon
🎟💙Rolvedon
eflapegrastim-xnst · Assertio
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Chemotherapy-induced neutropenia drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |